World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
6929
World Ranking
18472
National Ranking
7538

Ming Zhao publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ming Zhao sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 180 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ming Zhao D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ming Zhao sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 48 D-Index — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ming Zhao is affiliated with Pfizer in the United States and has a significant record of research and publications primarily in the field of Medicine. Their work spans subfields including Hepatology, Oncology, Pulmonary and Respiratory Medicine, Epidemiology, and Surgery. The main focus has been on hepatocellular carcinoma treatment and prognosis, with additional contributions to studies on cholangiocarcinoma and gallbladder cancer, liver disease diagnosis and treatment, cancer mechanisms and therapy, pancreatic and hepatic oncology, ferroptosis and cancer prognosis, and general cancer research and treatments.

Major recent publications by Ming Zhao include:

  • Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition), 2023, Liver Cancer
  • IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin, 2021, Journal of Hematology & Oncology
  • Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition), 2022, HepatoBiliary Surgery and Nutrition
  • Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma, 2020, Liver Cancer
  • Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma, 2021, Journal for ImmunoTherapy of Cancer

The frequent co-authors collaborating with Ming Zhao include Ning Lyu, Qifeng Chen, Minshan Chen, Robert M. Hoffman, and Jun-Zhe Yi. These collaborations indicate a multidisciplinary and possibly international network of research.

Ming Zhao's research has been published in several notable venues, frequently appearing in the Journal of Clinical Oncology, Liver Cancer, Frontiers in Oncology, Journal of Vascular and Interventional Radiology, and In Vivo. The concentration of publications in these journals reflects consistent contributions to oncology and hepatology literature.

Best Publications

  • Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium

    Ming Zhao;Meng Yang;Xiao-Ming Li;Ping Jiang

  • Targeted Therapy with a Salmonella Typhimurium Leucine-Arginine Auxotroph Cures Orthotopic Human Breast Tumors in Nude Mice

    Ming Zhao;Meng Yang;Huaiyu Ma;Xiaoming Li

  • Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer

    Ming Zhao;Jack Geller;Huaiyu Ma;Meng Yang

  • Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models

    Yukihiko Hiroshima;Yong Zhang;Takashi Murakami;Ali Maawy

  • Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.

    Clinton Yam;Clinton Yam;Ming Zhao;Katsuhiro Hayashi;Katsuhiro Hayashi;Huaiyu Ma

  • Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.

    Chisa Nagakura;Katsuhiro Hayashi;Ming Zhao;Kensuke Yamauchi

  • In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation

    Hiroyuki Kishimoto;Ming Zhao;Katsuhiro Hayashi;Yasuo Urata

  • Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium.

    Katsuhiro Hayashi;Ming Zhao;Kensuke Yamauchi;Norio Yamamoto

  • Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium

    Katsuhiro Hayashi;Ming Zhao;Kensuke Yamauchi;Norio Yamamoto

  • Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity

    Fang Liu;Lei Zhang;Robert M Hoffman;Ming Zhao

  • Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy

    Shuya Yano;Yong Zhang;Ming Zhao;Yukihiko Hiroshima

  • The bulge area is the major hair follicle source of nestin-expressing pluripotent stem cells which can repair the spinal cord compared to the dermal papilla.

    Fang Liu;Aisada Uchugonova;Hiroaki Kimura;Chuansen Zhang

  • High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model

    Tasuku Kiyuna;Takashi Murakami;Yasunori Tome;Kei Kawaguchi

  • Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.

    Yang Sun;Qian-Mei Zhou;Yi-Yu Lu;Hui Zhang

  • Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals.

    Ming Zhao;Meng Yang;Eugene Baranov;Xiaoen Wang

  • Efficacy of Salmonella typhimurium A1‐R Versus Chemotherapy on a Pancreatic Cancer Patient‐Derived Orthotopic Xenograft (PDOX)

    Yukihiko Hiroshima;Yukihiko Hiroshima;Ming Zhao;Ali Maawy;Yong Zhang

  • Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

    Mako Yamamoto;Ming Zhao;Yukihiko Hiroshima;Yong Zhang

  • Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium

    Hiroaki Kimura;Lynn Zhang;Ming Zhao;Katsuhiro Hayashi

  • Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.

    Kei Kawaguchi;Kentaro Igarashi;Takashi Murakami;Bartosz Chmielowski

  • Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model

    Masashi Momiyama;Ming Zhao;Hiroaki Kimura;Benjamin Tran

Frequent Co-Authors

Robert M. Hoffman
Robert M. Hoffman AntiCancer (United States)
Michael Bouvet
Michael Bouvet University of California, San Diego
Itaru Endo
Itaru Endo Yokohama City University
Toshiyoshi Fujiwara
Toshiyoshi Fujiwara Okayama University
Katsuro Tomita
Katsuro Tomita Kanazawa University
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
Michiaki Unno
Michiaki Unno Tohoku University
Michael McClelland
Michael McClelland University of California, Irvine
Steffen Porwollik
Steffen Porwollik APEX Think Consulting

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of flexible online degree programs and diverse career pathways in the healthcare and life sciences sectors. For those looking to enter healthcare quickly, an online asn degree provides foundational training and prepares graduates for critical nursing roles.

Students interested in nutrition and health sciences can prepare for careers as dietitians by earning an online dietitian degree. These programs focus on human biology, dietary needs, and wellness, making graduates valuable in clinical, community, and corporate settings.

Those considering leadership in health administration should explore top cahme-accredited mha programs. These programs help students develop managerial, analytical, and strategic skills crucial for managing hospitals, clinics, and healthcare organizations.

Lastly, for advanced clinical roles without traditional clinical hours, dnp program no clinical options provide opportunities to deepen expertise in evidence-based practice, healthcare policy, and leadership.

Best Scientists Citing Ming Zhao

Trending Scientists

Recently Published Articles